|
1) Namboodiri KK, Kaplan EB, Heuch I, et al. The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol. 1985; 2: 227-54
|
|
|
|
2) Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008; 40: 161-9
|
|
|
|
|
|
3) Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008; 40: 189-97
|
|
|
|
|
|
4) Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009; 41: 56-65
|
|
|
|
|
|
5) Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466: 707-13
|
|
|
|
|
|
6) Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010; 42: 210-5
|
|
|
|
|
|
7) Nakayama K, Bayasgalan T, Yamanaka K, et al. Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J Med Genet. 2009; 46: 370-4
|
|
|
|
|
|
8) Nakayama K, Bayasgalan T, Tazoe F, et al. A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle. Hum Genet. 2010; 127: 685-90
|
|
|
|
|
|
9) Horie Y, Fazio S, Westerlund JR, et al. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem. 1992; 267: 1962-8
|
|
|
|
|
|
10) Lau PP, Zhu HJ, Baldini A, et al. Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci U S A. 1994; 91: 8522-6
|
|
|
|
|
|
11) Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010; 466: 714-9
|
|
|
|
|
|
12) Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13. 3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010; 12: 213–23
|
|
|
|
|
|
13) Brown ML, Inazu A, Hesler CB, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989; 342: 448-51
|
|
|
|
|
|
14) Takahashi K, Jiang XC, Sakai N, et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest. 1993; 92: 2060-4
|
|
|
|
|
|
15) Isaacs A, Sayed-Tabatabaei FA, Njajou OT, et al. The -514 C-T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocr Metab. 2004; 89: 3858-63
|
|
|
|
|
|
16) Suviolahti E, Lilja HE, Pajukanta P. Unraveling the complex genetics of familial combined hyperlipidemia. Ann Med. 2006; 38: 337-51
|
|
|
|
|
|
17) Rip J, Nierman MC, Ross CJ, et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol. 2006; 26: 1236-45
|
|
|
|
|
|
18) Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem. 2002; 277: 33742-8
|
|
|
|
|
|
19) Schjoldager KT, Vester-Christensen MB, Bennett EP. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids. J Biol Chem. 2010; 285: 36293-303
|
|
|
|
|
|
20) Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet. 2009; 18: 4081-8
|
|
|
|
|
|
21) Burkhardt R, Toh SA, Lagor WR, et al. Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest. 2010; 120: 4410-4
|
|
|
|
|
|
22) Kabashima T, Kawaguchi T, Wadzinski BE, et al. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A. 2003; 100: 5107-12
|
|
|
|
|
|
23) Lai CQ, Corella D, Demissie S, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006; 113: 2062-70
|
|
|
|
|
|
24) Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet. 2010; 42: 684-7
|
|
|
|
|